EURAP registry: inadequate monitoring of prescribed drugs in pregnancy - Authors' reply

doi:10.1016/S1474-4422(18)30281-3

Comment

. 2018 Sep;17(9):741-742.

doi: 10.1016/S1474-4422(18)30281-3.

EURAP registry: inadequate monitoring of prescribed drugs in pregnancy - Authors' reply

Torbjörn Tomson¹, Dina Battino², Erminio Bonizzoni³, John Craig⁴, Dick Lindhout⁵, Emilio Perucca⁶, Anne Sabers⁷, Sanjeev V Thomas⁸, Frank Vajda⁹

Affiliations

¹ Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Neurology, Karolinska University Hospital, Stockholm, Sweden. Electronic address: torbjorn.tomson@sll.se.
² Epilepsy Center, Department of Neurophysiology and Experimental Epileptology, IRCCS Neurological Institute Carlo Besta Foundation, Milan, Italy.
³ Department of Clinical Science and Community, Section of Medical Statistics, Biometry and Epidemiology, Faculty of Medicine and Surgery, University of Milan, Milan, Italy.
⁴ Department of Neurosciences, Acute and Unscheduled Care, Belfast Health and Social Care Trust, Belfast, UK.
⁵ Department of Genetics, University Medical Center Utrecht, Utrecht, Netherlands; Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, Netherlands.
⁶ Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy; Clinical Trial Center, IRCCS Mondino Foundation, Pavia, Italy.
⁷ The Epilepsy Clinic, Department of Neurology, Rigshospitalet-Blegdamsvej, University State Hospital, Copenhagen, Denmark.
⁸ Department of Neurology, Sree ChitraTirunal Institute of Medical Sciences and Technology, Trivandrum, Kerala, India.
⁹ Department of Medicine and Department of Neurology, University of Melbourne, Royal Melbourne Hospital, Melbourne, VIC, Australia.

PMID: 30129470
DOI: 10.1016/S1474-4422(18)30281-3

Comment

EURAP registry: inadequate monitoring of prescribed drugs in pregnancy - Authors' reply

Torbjörn Tomson et al. Lancet Neurol. 2018 Sep.

. 2018 Sep;17(9):741-742.

doi: 10.1016/S1474-4422(18)30281-3.

Authors

Torbjörn Tomson¹, Dina Battino², Erminio Bonizzoni³, John Craig⁴, Dick Lindhout⁵, Emilio Perucca⁶, Anne Sabers⁷, Sanjeev V Thomas⁸, Frank Vajda⁹

Affiliations

¹ Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Neurology, Karolinska University Hospital, Stockholm, Sweden. Electronic address: torbjorn.tomson@sll.se.
² Epilepsy Center, Department of Neurophysiology and Experimental Epileptology, IRCCS Neurological Institute Carlo Besta Foundation, Milan, Italy.
³ Department of Clinical Science and Community, Section of Medical Statistics, Biometry and Epidemiology, Faculty of Medicine and Surgery, University of Milan, Milan, Italy.
⁴ Department of Neurosciences, Acute and Unscheduled Care, Belfast Health and Social Care Trust, Belfast, UK.
⁵ Department of Genetics, University Medical Center Utrecht, Utrecht, Netherlands; Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, Netherlands.
⁶ Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy; Clinical Trial Center, IRCCS Mondino Foundation, Pavia, Italy.
⁷ The Epilepsy Clinic, Department of Neurology, Rigshospitalet-Blegdamsvej, University State Hospital, Copenhagen, Denmark.
⁸ Department of Neurology, Sree ChitraTirunal Institute of Medical Sciences and Technology, Trivandrum, Kerala, India.
⁹ Department of Medicine and Department of Neurology, University of Melbourne, Royal Melbourne Hospital, Melbourne, VIC, Australia.

PMID: 30129470
DOI: 10.1016/S1474-4422(18)30281-3

No abstract available

PubMed Disclaimer

Comment on

Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F; EURAP Study Group. Tomson T, et al. Lancet Neurol. 2018 Jun;17(6):530-538. doi: 10.1016/S1474-4422(18)30107-8. Epub 2018 Apr 18. Lancet Neurol. 2018. PMID: 29680205
EURAP registry: inadequate monitoring of prescribed drugs in pregnancy.
Braillon A, Bewley S. Braillon A, et al. Lancet Neurol. 2018 Sep;17(9):741. doi: 10.1016/S1474-4422(18)30280-1. Lancet Neurol. 2018. PMID: 30129471 No abstract available.

Cited by

Safety concerns of maternal antiseizure medications exposure on perinatal and offspring outcomes: a disproportionality analysis based on FDA adverse event reporting system.
Zeng Y, Lin W, Zhuang W. Zeng Y, et al. J Neurol. 2025 May 28;272(6):429. doi: 10.1007/s00415-025-13172-3. J Neurol. 2025. PMID: 40434447

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

EURAP registry: inadequate monitoring of prescribed drugs in pregnancy - Authors' reply

Affiliations

EURAP registry: inadequate monitoring of prescribed drugs in pregnancy - Authors' reply

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical